MedPath

Etoricoxib

Generic Name
Etoricoxib
Drug Type
Small Molecule
Chemical Formula
C18H15ClN2O2S
CAS Number
202409-33-4
Unique Ingredient Identifier
WRX4NFY03R

Overview

Etoricoxib is a new COX-2 selective inhibitor. Current therapeutic indications are: treatment of rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, chronic low back pain, acute pain and gout. Like any other COX-2 selective inhibitor, Etoricoxib selectively inhibits isoform 2 of cyclo-oxigenase enzyme (COX-2) to reduce the generation of prostaglandins (PGs) from arachidonic acid. It is approved in more than 60 countries worldwide but not in the US.

Indication

For the treatment of rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, chronic low back pain, acute pain and gout.

Associated Conditions

  • Ankylosing Spondylitis (AS)
  • Gout
  • Osteoarthritis (OA)
  • Rheumatoid Arthritis
  • Moderate Pain

Clinical Trials

View More Clinical Trials

Sign in to access the complete clinical trial database with detailed study information.

Title
Posted
Study ID
Phase
Status
Sponsor
2021/12/02
Early Phase 1
UNKNOWN
2021/07/20
Phase 3
Completed
2021/04/05
Phase 1
UNKNOWN
2020/09/25
Phase 2
Completed
2020/07/08
Phase 2
UNKNOWN
Shanghai Yueyang Integrated Medicine Hospital
2019/10/30
Phase 4
Completed
2018/07/11
Phase 4
Completed
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
2018/06/01
Not Applicable
Completed
2018/02/05
Not Applicable
Completed
Dexa Medica Group
2017/01/05
Phase 3
Completed
Oslo University Hospital

FDA Drug Approvals

View More FDA Approvals

Sign in to access additional FDA-approved drug information with detailed regulatory data.

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
No FDA approvals found for this drug.

EMA Drug Approvals

View More EMA Approvals

Sign in to access additional EMA-approved drug information with detailed regulatory data.

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

View More HSA Approvals

Sign in to access additional HSA-approved drug information with detailed regulatory data.

NMPA Drug Approvals

View More NMPA Approvals

Sign in to access additional NMPA-approved drug information with detailed regulatory data.

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

View More PPB Approvals

Sign in to access additional PPB-approved drug information with detailed regulatory data.

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

View More TGA Approvals

Sign in to access additional TGA-approved drug information with detailed regulatory data.

Health Canada Drug Approvals

View More Health Canada Approvals

Sign in to access additional Health Canada approved drug information with detailed regulatory data.

Approved Product
Company
DIN
Dosage Form
Strength
Market Date
No Health Canada approvals found for this drug.

CIMA AEMPS Drug Approvals

View More CIMA AEMPS Approvals

Sign in to access additional CIMA AEMPS approved drug information with detailed regulatory data.

Approved Product
Company
Registration Number
Pharmaceutical Form
Prescription Type
Status
ETORICOXIB ZENTIVA 30 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
81671
COMPRIMIDO RECUBIERTO CON PELÍCULA
Medicamento Sujeto A Prescripción Médica
Not Commercialized
ETORICOXIB TECNIGEN 30 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Tecnimede España Industria Farmaceutica S.A.
82960
COMPRIMIDO RECUBIERTO CON PELÍCULA
Medicamento Sujeto A Prescripción Médica
Not Commercialized
ACOXXEL 30 mg COMPRIMIDOS RECUBIERTOS CON PELICULA
Organon Salud S.L.
71587
COMPRIMIDO RECUBIERTO CON PELÍCULA
Medicamento Sujeto A Prescripción Médica
Commercialized
ETORICOXIB VIR 120 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Industria Quimica Y Farmaceutica Vir S.A.
81465
COMPRIMIDO RECUBIERTO CON PELÍCULA
Medicamento Sujeto A Prescripción Médica
Commercialized
ETORICOXIB TAD 30 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
82829
COMPRIMIDO RECUBIERTO CON PELÍCULA
Medicamento Sujeto A Prescripción Médica
Not Commercialized
ETORICOXIB COMBIX 120 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Laboratorios Combix S.L.U.
81956
COMPRIMIDO RECUBIERTO CON PELÍCULA
Medicamento Sujeto A Prescripción Médica
Not Commercialized
BALIXUM 60 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Laboratorio Stada S.L.
84236
COMPRIMIDO RECUBIERTO CON PELÍCULA
Medicamento Sujeto A Prescripción Médica
Not Commercialized
ARCOXIA 30 mg COMPRIMIDOS RECUBIERTOS CON PELICULA
Organon Salud S.L.
69376
COMPRIMIDO RECUBIERTO CON PELÍCULA
Medicamento Sujeto A Prescripción Médica
Commercialized
ETORICOXIB GOBENS 60 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Laboratorios Normon S.A.
82070
COMPRIMIDO RECUBIERTO CON PELÍCULA
Medicamento Sujeto A Prescripción Médica
Not Commercialized
ETORICOXIB TAD 60 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
82830
COMPRIMIDO RECUBIERTO CON PELÍCULA
Medicamento Sujeto A Prescripción Médica
Not Commercialized

Philippines FDA Drug Approvals

View More Philippines FDA Approvals

Sign in to access additional Philippines FDA approved drug information with detailed regulatory data.

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Philippines FDA approvals found for this drug.

Saudi SFDA Drug Approvals

View More Saudi SFDA Approvals

Sign in to access additional Saudi SFDA approved drug information with detailed regulatory data.

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Saudi SFDA approvals found for this drug.

Malaysia NPRA Drug Approvals

View More Malaysia NPRA Approvals

Sign in to access additional Malaysia NPRA approved drug information with detailed regulatory data.

Approved Product
Company
Registration Number
Dosage Form
Strength
Approval Date
No Malaysia NPRA approvals found for this drug.

UK EMC Drug Information

View More UK EMC Drug Information

Sign in to access additional UK EMC drug information with detailed pharmaceutical data.

Medicine Name
MA Holder
MA Number
Pharmaceutical Form
Active Ingredient
Authorization Date
No UK EMC drug information found for this drug.

Help Us Improve

Your feedback helps us provide better drug information and insights.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.